Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-11 Purchase | 2026-05-13 5:10 pm | Odyssey Therapeutics Inc. | ODTX | TPG GP A LLC COULTER JAMES G WINKELRIED JON Former 10% Owner | 1,388,889 | $18 | $25,000,002 | 4,115,608 (Indirect) | View |
| 2026-05-08 Purchase | 2026-05-12 5:37 pm | Odyssey Therapeutics Inc. | ODTX | Dimension Capital II L.P. Director | 1,111,111 | $18 | $19,999,998 | 3,333,516 (Direct) | View |
| 2026-05-11 Purchase | 2026-05-11 9:11 pm | Odyssey Therapeutics Inc. | ODTX | SR ONE CAPITAL MANAGEMENT LLC George Simeon 10% Owner | 555,555 | $18 | $9,999,990 | 1,014,851 (Indirect) | View |
| 2026-05-11 Sale | 2026-05-11 9:11 pm | Odyssey Therapeutics Inc. | ODTX | SR ONE CAPITAL MANAGEMENT LLC George Simeon 10% Owner | 1,780 | $18 | $32,040 | 1,014,851 (Indirect) | View |
| 2026-05-08 Purchase | 2026-05-11 8:35 pm | Odyssey Therapeutics Inc. | ODTX | LEIDEN JEFFREY M Director | 5,000 | $20 | $100,000 | 928,062 (Indirect Direct) | View |
| 2026-05-08 Purchase | 2026-05-11 8:32 pm | Odyssey Therapeutics Inc. | ODTX | Haas Jason Chief Financial Officer | 1,000 | $20 | $20,000 | 62,908 (Direct) | View |
| 2026-05-11 Purchase | 2026-05-11 8:30 pm | Odyssey Therapeutics Inc. | ODTX | Li Nan (LN) Director | 1,111,111 | $18 | $19,999,998 | 3,333,516 (Indirect) | View |
| 2026-05-11 Purchase | 2026-05-11 8:30 pm | Odyssey Therapeutics Inc. | ODTX | Chu Shelley Director | 11,111 | $18 | $199,998 | 11,111 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-11 Conversion | 2026-05-13 5:10 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | TPG GP A LLC COULTER JAMES G WINKELRIED JON Former 10% Owner | 20,153,286 | $0 | 4,115,608 (Indirect) | View |
| 2026-05-11 Other | 2026-05-13 5:10 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | TPG GP A LLC COULTER JAMES G WINKELRIED JON Former 10% Owner | 2,351 | $18 | 4,115,608 (Indirect) | View |
| 2026-05-11 Other | 2026-05-13 5:10 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | TPG GP A LLC COULTER JAMES G WINKELRIED JON Former 10% Owner | 423,111 | $0 | 4,115,608 (Indirect) | View |
| 2026-05-08 Conversion | 2026-05-12 5:37 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Dimension Capital II L.P. Director | 18,321,169 | $0 | 3,333,516 (Direct) | View |
Ownership | 2026-05-12 5:36 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Dimension Capital II L.P. Director | 0 | $0 | 2,222,405 (Direct) | View |
| 2026-05-11 Conversion | 2026-05-11 9:11 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | SR ONE CAPITAL MANAGEMENT LLC George Simeon 10% Owner | 31,015,232 | $0 | 1,014,851 (Indirect) | View |
| 2026-05-11 Exercise | 2026-05-11 9:11 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | SR ONE CAPITAL MANAGEMENT LLC George Simeon 10% Owner | 3,429,965 | $0 | 1,014,851 (Indirect) | View |
| 2026-05-11 Conversion | 2026-05-11 8:35 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | LEIDEN JEFFREY M Director | 303,866 | $0 | 928,062 (Indirect) | View |
| 2026-05-11 Exercise | 2026-05-11 8:35 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | LEIDEN JEFFREY M Director | 31,763 | $0 | 928,062 (Indirect) | View |
| 2026-05-07 Option Award | 2026-05-11 8:35 pm | N/A 2036-05-06 | Odyssey Therapeutics Inc. | ODTX | LEIDEN JEFFREY M Director | 626,220 | $0 | 928,062 (Direct) | View |
| 2026-05-11 Tax Withholding | 2026-05-11 8:35 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | LEIDEN JEFFREY M Director | 17 | $18 | 928,062 (Indirect) | View |
| 2026-05-11 Conversion | 2026-05-11 8:30 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Li Nan (LN) Director | 18,321,169 | $0 | 3,333,516 (Indirect) | View |
| 2026-05-07 Option Award | 2026-05-11 8:30 pm | N/A 2036-05-06 | Odyssey Therapeutics Inc. | ODTX | SMITH IAN F Director | 27,393 | $0 | 27,393 (Direct) | View |
| 2026-05-07 Option Award | 2026-05-11 8:30 pm | N/A 2036-05-06 | Odyssey Therapeutics Inc. | ODTX | Odegard Valerie Director | 27,393 | $0 | 27,393 (Direct) | View |
| 2026-05-07 Option Award | 2026-05-11 8:30 pm | N/A 2036-05-06 | Odyssey Therapeutics Inc. | ODTX | Tatsis Ourania Director | 27,393 | $0 | 27,393 (Direct) | View |
| 2026-05-07 Option Award | 2026-05-11 8:30 pm | N/A 2036-05-06 | Odyssey Therapeutics Inc. | ODTX | Dales Natalie See Remarks | 79,773 | $0 | 79,773 (Direct) | View |
| 2026-05-07 Option Award | 2026-05-11 8:30 pm | N/A 2036-05-06 | Odyssey Therapeutics Inc. | ODTX | Walbert Timothy P Director | 27,393 | $0 | 27,393 (Direct) | View |
| 2026-05-11 Conversion | 2026-05-11 8:30 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Glick Gary D See Remarks | 293,502 | $0 | 1,300,423 (Direct) | View |
| 2026-05-07 Option Award | 2026-05-11 8:30 pm | N/A 2036-05-06 | Odyssey Therapeutics Inc. | ODTX | Glick Gary D See Remarks | 884,450 | $0 | 1,300,423 (Direct) | View |
| 2026-05-11 Conversion | 2026-05-11 8:30 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Opipari Anthony W. See Remarks | 74,124 | $0 | 285,482 (Direct) | View |
| 2026-05-11 Exercise | 2026-05-11 8:30 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Opipari Anthony W. See Remarks | 5,804 | $0 | 285,482 (Direct) | View |
| 2026-05-07 Option Award | 2026-05-11 8:30 pm | N/A 2036-05-06 | Odyssey Therapeutics Inc. | ODTX | Opipari Anthony W. See Remarks | 277,980 | $0 | 285,482 (Direct) | View |
| 2026-05-11 Tax Withholding | 2026-05-11 8:30 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Opipari Anthony W. See Remarks | 4 | $18 | 285,482 (Direct) | View |
| 2026-05-07 Option Award | 2026-05-11 8:30 pm | N/A 2036-05-06 | Odyssey Therapeutics Inc. | ODTX | Todd Collin M See Remarks | 93,904 | $0 | 93,904 (Direct) | View |
Ownership | 2026-05-07 9:45 pm | N/A 2034-11-03 | Odyssey Therapeutics Inc. | ODTX | Walbert Timothy P Director | 0 | $0 | 196,496 (Direct) | View |
Ownership | 2026-05-07 9:40 pm | N/A 2031-10-06 | Odyssey Therapeutics Inc. | ODTX | Odegard Valerie Director | 0 | $0 | 196,493 (Direct) | View |
Ownership | 2026-05-07 9:39 pm | N/A 2035-09-18 | Odyssey Therapeutics Inc. | ODTX | Tatsis Ourania Director | 0 | $0 | 196,497 (Direct) | View |
Ownership | 2026-05-07 9:34 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Dales Natalie See Remarks | 0 | $0 | 82,363 (Direct) | View |
Ownership | 2026-05-07 9:31 pm | N/A 2031-10-06 | Odyssey Therapeutics Inc. | ODTX | Opipari Anthony W. See Remarks | 0 | $0 | 91,442 (Direct) | View |
Ownership | 2026-05-07 9:31 pm | N/A 2036-03-11 | Odyssey Therapeutics Inc. | ODTX | Siegel Jolie See Remarks | 0 | $0 | 78,958 (Direct) | View |
Ownership | 2026-05-07 9:30 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Li Nan (LN) Director | 0 | $0 | 2,222,405 (Indirect) | View |
Ownership | 2026-05-07 9:28 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | LEIDEN JEFFREY M Director | 0 | $0 | 620,499 (Direct) | View |
Ownership | 2026-05-07 9:28 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | SR ONE CAPITAL MANAGEMENT LLC George Simeon 10% Owner | 0 | $0 | 3,241,108 (Indirect) | View |
Ownership | 2026-05-07 9:27 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Glick Gary D See Remarks | 0 | $0 | 2,185,711 (Direct) | View |
Ownership | 2026-05-07 9:23 pm | N/A 2032-06-29 | Odyssey Therapeutics Inc. | ODTX | Todd Collin M See Remarks | 0 | $0 | 179,480 (Direct) | View |
Ownership | 2026-05-07 9:23 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | SMITH IAN F Director | 0 | $0 | 246,100 (Direct) | View |
Ownership | 2026-05-07 9:23 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | TPG GP A LLC COULTER JAMES G WINKELRIED JON 10% Owner | 0 | $0 | 2,303,608 (Indirect) | View |
Ownership | 2026-05-07 9:22 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | Haas Jason Chief Financial Officer | 0 | $0 | 346,221 (Direct) | View |
Ownership | 2026-05-07 9:22 pm | N/A N/A | Odyssey Therapeutics Inc. | ODTX | NG CAROLYN Director | 0 | $0 | 0 (Direct) | View |